Bryan Anger

Punter

Age: 32
Free Agency: 2023 (UFA)
Accrued Seasons: 8
  • 2020 Salary Cap Charge: $2,416,666 (1.11% of cap)
  • 2020 Cash Payout: $3,250,000 (1.44% of spending)
  • 2020 Cash to Cap Ratio: 1.34
  • Contract Value: $8,250,000 ($2,750,000 APY)
  • Fully Guaranteed Money: $1,250,000
  • Contract Ranking: 9/40 at P

Current Contract

(UFA, signed 2020)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusRoster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202032$1,250,000$416,666$750,000$750,000$2,416,6661.1%
202133$2,500,000$416,666$0$0$2,916,6661.4%
202234$2,500,000$416,668$0$0$2,916,6681.3%
Total$6,250,000$1,250,000$750,000$750,000$8,250,000

Contract Notes

Bryan Anger signed a three year extension with the Houston Texans on January 13, 2020.  The contract is worth $8.25 million with $1.25 million guaranteed at signing with a total guarantee of $2 million.  Anger received a $1.25 million signing bonus.  Anger is due a $750,000 roster bonus after the start of the 2020 league year, the bonus is guaranteed for skill and injury at signing.  We suspect the roster bonus will vest to a full guarantee three days after signing.
Career Earnings: $13,697,754
Career APY: $1,712,219
Potential Earnings: $20,697,754
Total Guarantees: $4,432,500
Largest Cash Payment: $4,000,000 (2017)
Largest Cap Number: $4,175,000 (2017)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
JaguarsDraftedExpired20124$2,877,166$719,292$662,500$2,877,166100.0%$719,292
BuccaneersExtensionTerminated20165$17,000,000$3,400,000$2,500,000$8,750,00051.5%$2,916,667
TexansSFATerminated20191$1,000,000$1,000,000$20,000$00.0%$0
TexansSFAExpired20191$930,000$930,000$0$820,58888.2%$820,588
TexansUFAActive20203$8,250,000$2,750,000$1,250,000$1,250,00015.2%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Jaguars4$2,877,166$719,292$2,877,1660.0%$00.0%
Buccaneers3$8,750,000$2,916,667$8,925,0000.0%$00.0%
Texans1$2,070,588$2,070,588$569,1180.0%$20,0000.0%

Salary Cap History

YearTeamBase SalaryProrated BonusRoster BonusWorkout BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2012Jaguars$390,000$165,625$0$0$0$0$555,6250.5%$1,052,500
2013Jaguars$509,913$165,625$0$0$0$0$675,5380.5%$509,913
2014Jaguars$584,898$165,625$0$20,000$0$0$770,5230.5%$604,898
2015Jaguars$689,855$165,625$0$20,000$0$0$875,4800.5%$709,855
2016Buccaneers$1,000,000$0$750,000$0$0$750,000$1,750,0001.1%$1,750,000
2017Buccaneers$1,500,000$0$2,500,000$0$175,000$2,500,000$4,175,0002.4%$4,000,000
2018Buccaneers$3,000,000$0$0$0$0$0$3,000,0001.5%$3,000,000
2019Texans$930,000$0$0$0$0$0$569,1180.3%$820,588
2020Texans$1,250,000$416,666$750,000$0$0$750,000$2,416,6661.1%$3,250,000
2021Texans$2,500,000$416,666$0$0$0$0$2,916,6661.4%$2,500,000
2022Texans$2,500,000$416,668$0$0$0$0$2,916,6681.3%$2,500,000
Total$14,854,666$1,912,500$4,000,000$40,000$175,000$4,000,000$20,621,284$20,697,754
Dead Money History
TeamYearCap ChargeCash Paid
Texans2019$20,000$20,000
Total$20,000$20,000

Statistics

YearGames PlayedGames MissedSnaps
InjuredHealthySpecial
201216----29.6%
2013160031.3%
2014160032.1%
2015160030.7%
2016160031.3%
2017150026.4%
2018160028.9%
2019140026.2%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$829,000$2,750,000
Injury Adjusted$829,000$2,750,000
test
OTC Valuation $527.2k $1.1M $1.6M $2.1M $2.6M APY $650.0k $1.3M $2.0M $2.6M $3.3M $1,967,000 $2,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.